BioNxt Solutions Inc. (CNSX: BNXT)
Health Care · Pharmaceuticals · CA
CA$0.33
-14.47% today · -62.2% 1Y
BioNxt Solutions Inc. (CNSX: BNXT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $31.00M and employs 25 people.
Over the last twelve months the share price has lost 62.2%, trading between 0.28 and 0.91.
Tweenvest scores BioNxt Solutions Inc. across four factors: quality 10/100, value 49/100. Its strongest factor is value.
BNXT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.00M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.07
- Dividend yield
- —
- Beta (5Y)
- 1.42
- 52-week high
- CA$0.91
- 52-week low
- CA$0.28
- Avg volume (3M)
- —
- Shares outstanding
- 136.09M
- Employees
- 25
- Next earnings
- —
About BioNxt Solutions Inc.
Headquartered in Vancouver, Canada, BioNxt Solutions Inc., established in 2017, operates as a bioscience company across Germany, Switzerland, Austria, Israel, and its home country. The firm focuses on developing innovative drug delivery systems, including transdermal patches and oral dissolvable films, specifically for neurological medications. It also advances psychedelic medicine applications to treat various mental health conditions such as depression, anxiety, addiction, and trauma-related stress disorder. Furthermore, BioNxt is engaged in creating point-of-care diagnostics, comprising rapid tests and biosensor screening tools, aimed at early disease detection, improved treatment efficacy, and enhanced disease management. This diagnostic portfolio features a COVID-19 PCR kit, alongside oral biosensors for peri-implantitis, H1N1 (swine flu), and H5N1 (avian flu). Complementing its development efforts, the company provides analytical testing and consulting services, and is involved in pathogen and oral health diagnostics, thin film drug formulation, and the production and formulation of psychedelic pharmaceuticals. The company adopted its current name in November 2022, having previously been known as XPhyto Therapeutics Corp.
- ISIN
- CA0909741062
- Founded
- 2017
- Listed since
- Aug 6, 2019
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SoftOx Solutions ASOB: SOFTX | $32.42M | Nkr0.12 | -8.17% |
| MYUNGMOON Pharm co.,LtdKOSE: A017180 | $31.98M | ₩1,286.00 | +1.02% |
| Ambalal Sarabhai Enterprises LimitedBSE: 500009 | $31.90M | Rs40.29 | +6.25% |
| MIRA Pharmaceuticals, Inc.NasdaqCM: MIRA | $31.33M | $0.75 | +2.11% |
| Sharp Therapeutics Corp.TSXV: SHRX | $30.85M | CA$— | — |
| Astal Laboratories LimitedBSE: 512600 | $30.84M | Rs68.14 | -2.01% |
| New Green Hemp Inc.OTCPK: NGHI | $30.79M | $— | — |
| Aarey Drugs & Pharmaceuticals LimitedBSE: 524412 | $30.64M | Rs104.20 | +1.12% |
Figures last refreshed Oct 11, 2026.